Status:
UNKNOWN
Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment
Lead Sponsor:
University of Sao Paulo
Conditions:
Blood Pressure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the importance of providing guidelines to patients via active telephone calls in blood pressure control and in the discontinuation of treatment among hypertens...
Detailed Description
To evaluate the importance of providing guidelines to patients via active telephone calls for blood pressure management and the discontinuation of treatment in hypertensive patients, using two treatme...
Eligibility Criteria
Inclusion
- The patients studied were those with essential hypertension who could receive telephone calls to be reminded of the dates of their medical appointments and to receive guidance about hypertension
- Patients were of both genders, from any ethnic background, over 18 years old and with body mass index below 40 kg/m2, and were enrolled in the study after signing a free and informed consent term
Exclusion
- Blood pressure \< 140/90 mm Hg without antihypertensive medication
- Pregnant women or nursing mothers
- Patients with secondary hypertension
- White-coat hypertension with systolic pressure ≥ 140 mm Hg and/or diastolic pressure ≥ 90 mm Hg at the doctor's office and awake mean systolic pressure \< 135 mm Hg or awake mean diastolic pressure \< 85 mm Hg without antihypertensive medication
- Malignant hypertension
- Presence of liver dysfunction evidenced by the patient's clinical history or by one of the liver function tests with levels twice the normal values (alkaline phosphatase, total bilirubin, aspartate aminotransferase)
- Patients with clinical conditions that might interfere with the total conformity with the study or those who might have increased risk for participating in the study
- Patients with previous history of hypersensitivity reaction to the study medications
- Patients with a history of alcoholism, drug abuse or mental disorders that might invalidate the free and informed consent or limit the patient's ability to meet the protocol rules
- Patients who had participated in any other studies involving investigational drugs or drugs already marketed within the previous month, before enrollment in this study or concomitantly with this study.
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00813722
Start Date
March 1 1999
End Date
June 1 2009
Last Update
December 23 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sao Paulo University
São Paulo, São Paulo, Brazil, 05403-900
2
University of Sao Paulo
São Paulo, São Paulo, Brazil, 05405-000